Pasquali I - Search Results

1

Supercritical extraction of carotenoids from Rosa canina L. hips and their formulation with beta-cyclodextrin.

Tozzi R, Mulinacci N, Storlikken K, Pasquali I, Vincieri FF, Bettini R. Tozzi R, et al. Among authors: pasquali i. AAPS PharmSciTech. 2008;9(2):693-700. doi: 10.1208/s12249-008-9100-6. Epub 2008 Jun 5. AAPS PharmSciTech. 2008. PMID: 18528762 Free PMC article.

2

Are pharmaceutics really going supercritical?

Pasquali I, Bettini R. Pasquali I, et al. Int J Pharm. 2008 Dec 8;364(2):176-87. doi: 10.1016/j.ijpharm.2008.05.014. Epub 2008 May 21. Int J Pharm. 2008. PMID: 18597957 Review.

3

Didanosine polymorphism in a supercritical antisolvent process.

Bettini R, Menabeni R, Tozzi R, Pranzo MB, Pasquali I, Chierotti MR, Gobetto R, Pellegrino L. Bettini R, et al. Among authors: pasquali i. J Pharm Sci. 2010 Apr;99(4):1855-70. doi: 10.1002/jps.21962. J Pharm Sci. 2010. PMID: 19827134

4

Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics.

Pasquali I, Bettini R, Giordano F. Pasquali I, et al. Eur J Pharm Sci. 2006 Mar;27(4):299-310. doi: 10.1016/j.ejps.2005.11.007. Epub 2006 Jan 4. Eur J Pharm Sci. 2006. PMID: 16388936 Review.

5

Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.

Pasquali I, Bettini R, Giordano F. Pasquali I, et al. Adv Drug Deliv Rev. 2008 Feb 14;60(3):399-410. doi: 10.1016/j.addr.2007.08.030. Epub 2007 Oct 5. Adv Drug Deliv Rev. 2008. PMID: 17964684 Review.

6

Swelling, melting point reduction and solubility of PEG 1500 in supercritical CO2.

Pasquali I, Comi L, Pucciarelli F, Bettini R. Pasquali I, et al. Int J Pharm. 2008 May 22;356(1-2):76-81. doi: 10.1016/j.ijpharm.2007.12.048. Epub 2008 Jan 17. Int J Pharm. 2008. PMID: 18294790

7

Primary microparticles and agglomerates of morphine for nasal insufflation.

Russo P, Sacchetti C, Pasquali I, Bettini R, Massimo G, Colombo P, Rossi A. Russo P, et al. Among authors: pasquali i. J Pharm Sci. 2006 Dec;95(12):2553-61. doi: 10.1002/jps.20604. J Pharm Sci. 2006. PMID: 16937333

8

Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler.

Buttini F, Pasquali I, Brambilla G, Copelli D, Alberi MD, Balducci AG, Bettini R, Sisti V. Buttini F, et al. Among authors: pasquali i. Pharm Res. 2016 Mar;33(3):701-15. doi: 10.1007/s11095-015-1820-1. Epub 2015 Nov 16. Pharm Res. 2016. PMID: 26572643 Free PMC article.

9

Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.

Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, Pasquali I. Buttini F, et al. Among authors: pasquali i. J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):167-78. doi: 10.1089/jamp.2015.1220. Epub 2015 Sep 10. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26355743 Free PMC article.

10

Optical diagnostics study of air flow and powder fluidisation in Nexthaler®--Part I: Studies with lactose placebo formulation.

Pasquali I, Merusi C, Brambilla G, Long EJ, Hargrave GK, Versteeg HK. Pasquali I, et al. Int J Pharm. 2015 Dec 30;496(2):780-91. doi: 10.1016/j.ijpharm.2015.10.072. Epub 2015 Nov 3. Int J Pharm. 2015. PMID: 26545309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters